Stock listing
ACW Stock Price, News, Filings & Events — Actinogen Medical Limited
Selected listing: ACW · ASX · AUD · AU
This page tracks Actinogen Medical Limited's ACW:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACW:ASX. ACW:ASX is the stock-level entry point for investors researching Actinogen Medical Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinogen Medical Limited (Ticker: ACW) is a public company based in Australia with a market capitalization of approximately AUD 106.6 million. The company focuses on developing innovative treatments for cognitive disorders. Actinogen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.

- Ticker
- ACW:ASX
- Asset type
- Stock
- Market cap
- $157.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- ASX
- Currency
- AUD
Actinogen Medical Limited ACW:ASX stock context
This page tracks Actinogen Medical Limited's ACW:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACW:ASX. ACW:ASX is the stock-level entry point for investors researching Actinogen Medical Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinogen Medical Limited (Ticker: ACW) is a public company based in Australia with a market capitalization of approximately AUD 106.6 million. The company focuses on developing innovative treatments for cognitive disorders. Actinogen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.
Latest news from Actinogen Medical Limited
Research Actinogen Medical Limited
Actinogen Medical Limited investor report
Review AI stock analysis and investor report context for ACW:ASX.
Actinogen Medical Limited company profile
View the public company page for Actinogen Medical Limited on 6ix.
Actinogen Medical Limited news
Read company news and market updates connected to Actinogen Medical Limited.
Actinogen Medical Limited investor events
Find investor webinars, events, and replay context for Actinogen Medical Limited.
Alternate listings
ATGGF:OTC
US · USD
Alternate listing for Actinogen Medical Limited; the primary context on this page is ACW:ASX.
A0MZH8:LS
DE · EUR
Alternate listing for Actinogen Medical Limited; the primary context on this page is ACW:ASX.
3AC:FWB
DE · EUR
Alternate listing for Actinogen Medical Limited; the primary context on this page is ACW:ASX.